KR20000075758A - 세포 집단으로부터 종양 세포를 제거하기위한 시스템 - Google Patents
세포 집단으로부터 종양 세포를 제거하기위한 시스템 Download PDFInfo
- Publication number
- KR20000075758A KR20000075758A KR1019997007829A KR19997007829A KR20000075758A KR 20000075758 A KR20000075758 A KR 20000075758A KR 1019997007829 A KR1019997007829 A KR 1019997007829A KR 19997007829 A KR19997007829 A KR 19997007829A KR 20000075758 A KR20000075758 A KR 20000075758A
- Authority
- KR
- South Korea
- Prior art keywords
- cells
- cell population
- tumor cells
- cell
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 210000004027 cell Anatomy 0.000 title claims description 235
- 210000004881 tumor cell Anatomy 0.000 title claims description 134
- 238000000034 method Methods 0.000 claims abstract description 104
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 56
- 210000004882 non-tumor cell Anatomy 0.000 claims description 29
- 238000002372 labelling Methods 0.000 claims description 16
- 230000001105 regulatory effect Effects 0.000 claims description 12
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 11
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 11
- 210000003494 hepatocyte Anatomy 0.000 claims description 10
- 238000000338 in vitro Methods 0.000 claims description 8
- 239000000427 antigen Substances 0.000 claims description 4
- 108091007433 antigens Proteins 0.000 claims description 4
- 102000036639 antigens Human genes 0.000 claims description 4
- -1 Gly-A Proteins 0.000 claims description 3
- 101150052863 THY1 gene Proteins 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 2
- 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 claims description 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 2
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 2
- 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 claims description 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 2
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims description 2
- 102100022338 Integrin alpha-M Human genes 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 5
- 231100000636 lethal dose Toxicity 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 22
- 230000008569 process Effects 0.000 description 17
- 108010004729 Phycoerythrin Proteins 0.000 description 10
- 210000005229 liver cell Anatomy 0.000 description 10
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 10
- 210000001185 bone marrow Anatomy 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 6
- 229910052753 mercury Inorganic materials 0.000 description 6
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 230000003394 haemopoietic effect Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 238000001574 biopsy Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 4
- 238000000608 laser ablation Methods 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 208000007660 Residual Neoplasm Diseases 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 238000010322 bone marrow transplantation Methods 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 231100000588 tumorigenic Toxicity 0.000 description 3
- 230000000381 tumorigenic effect Effects 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 231100000599 cytotoxic agent Toxicity 0.000 description 2
- 239000002254 cytotoxic agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100220044 Homo sapiens CD34 gene Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 206010039737 Scratch Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000011072 cell harvest Methods 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000196 chemotoxic Toxicity 0.000 description 1
- 230000002604 chemotoxic effect Effects 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- GLNDAGDHSLMOKX-UHFFFAOYSA-N coumarin 120 Chemical compound C1=C(N)C=CC2=C1OC(=O)C=C2C GLNDAGDHSLMOKX-UHFFFAOYSA-N 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 description 1
- 210000001621 ilium bone Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- OSQUFVVXNRMSHL-LTHRDKTGSA-M sodium;3-[(2z)-2-[(e)-4-(1,3-dibutyl-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)but-2-enylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonate Chemical compound [Na+].O=C1N(CCCC)C(=S)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 OSQUFVVXNRMSHL-LTHRDKTGSA-M 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0093—Purging against cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/0004—Microscopes specially adapted for specific applications
- G02B21/0088—Inverse microscopes
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/16—Microscopes adapted for ultraviolet illumination ; Fluorescence microscopes
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/36—Microscopes arranged for photographic purposes or projection purposes or digital imaging or video purposes including associated control and data processing arrangements
- G02B21/365—Control or image processing arrangements for digital or video microscopes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Optics & Photonics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Multimedia (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Physiology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/824,968 US5874266A (en) | 1997-03-27 | 1997-03-27 | Targeted system for removing tumor cells from cell populations |
| US8/824,968 | 1997-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20000075758A true KR20000075758A (ko) | 2000-12-26 |
Family
ID=25242769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019997007829A Ceased KR20000075758A (ko) | 1997-03-27 | 1998-03-27 | 세포 집단으로부터 종양 세포를 제거하기위한 시스템 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US5874266A (enExample) |
| EP (1) | EP1011697B1 (enExample) |
| JP (2) | JP4512206B2 (enExample) |
| KR (1) | KR20000075758A (enExample) |
| CN (1) | CN1251528A (enExample) |
| AT (1) | ATE349220T1 (enExample) |
| AU (1) | AU743239B2 (enExample) |
| BR (1) | BR9808068A (enExample) |
| CA (1) | CA2281112A1 (enExample) |
| DE (1) | DE69836747T2 (enExample) |
| WO (1) | WO1998042356A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190025251A (ko) * | 2017-09-01 | 2019-03-11 | 주식회사 코어파마 | 순환암세포를 선택적으로 사멸시키는 시스템 |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040139A (en) * | 1995-09-19 | 2000-03-21 | Bova; G. Steven | Laser cell purification system |
| EP2264428B1 (en) | 1997-01-31 | 2017-05-03 | Xy, Llc | Optical apparatus with focussing reflector for converging radiation onto a flow of particles |
| US6469779B2 (en) * | 1997-02-07 | 2002-10-22 | Arcturus Engineering, Inc. | Laser capture microdissection method and apparatus |
| EP1003429B1 (en) * | 1997-03-19 | 2008-09-24 | Lucid, Inc. | Cellular surgery utilizing confocal microscopy |
| US5874266A (en) * | 1997-03-27 | 1999-02-23 | Palsson; Bernhard O. | Targeted system for removing tumor cells from cell populations |
| US6534308B1 (en) | 1997-03-27 | 2003-03-18 | Oncosis, Llc | Method and apparatus for selectively targeting specific cells within a mixed cell population |
| US6753161B2 (en) * | 1997-03-27 | 2004-06-22 | Oncosis Llc | Optoinjection methods |
| US6514722B2 (en) | 1997-03-27 | 2003-02-04 | Oncosis | Method and apparatus for selectively targeting specific cells within a cell population |
| US6149867A (en) * | 1997-12-31 | 2000-11-21 | Xy, Inc. | Sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
| US6071689A (en) * | 1997-12-31 | 2000-06-06 | Xy, Inc. | System for improving yield of sexed embryos in mammals |
| US6642018B1 (en) * | 1998-03-27 | 2003-11-04 | Oncosis Llc | Method for inducing a response in one or more targeted cells |
| EP1073716B1 (en) * | 1998-04-28 | 2004-04-28 | Amersham Health AS | Improvements in or relating to separation processes |
| DE19916749B4 (de) * | 1999-04-14 | 2004-02-12 | Carl Zeiss Jena Gmbh | Verfahren zur Untersuchung von Proben |
| WO2001033190A2 (en) | 1999-11-04 | 2001-05-10 | Arcturus Engineering, Inc. | Automated laser capture microdissection |
| US7208265B1 (en) * | 1999-11-24 | 2007-04-24 | Xy, Inc. | Method of cryopreserving selected sperm cells |
| ES2346637T3 (es) * | 2000-03-27 | 2010-10-19 | Thomas Jefferson University | Composiciones y metodos para identificar y marcar celulas cancerosas originadas en el tubo digestivo. |
| WO2002019594A2 (en) * | 2000-08-02 | 2002-03-07 | Arizona Board Of Regents, Acting On Behalf Of Arizona State University | Scanning fluorescence lifetime microscope: directed evolution |
| WO2002022774A1 (en) * | 2000-09-12 | 2002-03-21 | Oncosis Llc | Chamber for laser-based processing |
| US20040031071A1 (en) * | 2000-10-05 | 2004-02-12 | Xy, Inc. | System of hysteroscopic insemination of mares |
| WO2002037938A2 (en) | 2000-10-24 | 2002-05-16 | Oncosis Llc | Method and device for selectively targeting cells within a three -dimensional specimen |
| US20030007894A1 (en) * | 2001-04-27 | 2003-01-09 | Genoptix | Methods and apparatus for use of optical forces for identification, characterization and/or sorting of particles |
| US7713687B2 (en) | 2000-11-29 | 2010-05-11 | Xy, Inc. | System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations |
| AU2002237689B2 (en) * | 2000-11-29 | 2008-01-10 | Xy, Llc. | System to separate frozen-thawed spermatozoa into X-chromosome bearing and Y-chromosome bearing populations |
| US20050143791A1 (en) * | 2001-07-09 | 2005-06-30 | Stuart Hameroff | Process of treating a cell |
| US8722357B2 (en) | 2001-11-05 | 2014-05-13 | Life Technologies Corporation | Automated microdissection instrument |
| US10156501B2 (en) | 2001-11-05 | 2018-12-18 | Life Technologies Corporation | Automated microdissection instrument for determining a location of a laser beam projection on a worksurface area |
| US20040002154A1 (en) * | 2002-04-19 | 2004-01-01 | Palsson Bernhard O. | Methods for preparing libraries of unique tags and related screening methods |
| AU2003259205B2 (en) * | 2002-07-22 | 2009-10-08 | Xy, Llc. | Sperm cell process system |
| US8486618B2 (en) | 2002-08-01 | 2013-07-16 | Xy, Llc | Heterogeneous inseminate system |
| EP2283724B8 (en) * | 2002-08-01 | 2016-03-16 | Xy, Llc | Heterospermic insemination to assess sperm function |
| MXPA05001654A (es) * | 2002-08-15 | 2005-10-18 | Xy Inc | Citometro de flujo de alta resolucion. |
| US7169548B2 (en) | 2002-09-13 | 2007-01-30 | Xy, Inc. | Sperm cell processing and preservation systems |
| EP2305171B1 (en) | 2003-03-28 | 2021-12-29 | Inguran, LLC | Apparatus and methods for providing sex-sorted animal sperm |
| NZ544103A (en) * | 2003-05-15 | 2010-10-29 | Xy Llc | Efficient haploid cell sorting for flow cytometer systems |
| US7776584B2 (en) * | 2003-08-01 | 2010-08-17 | Genetix Limited | Animal cell colony picking apparatus and method |
| WO2005022147A1 (en) | 2003-08-28 | 2005-03-10 | Celula, Inc. | Methods and apparatus for sorting cells using an optical switch in a microfluidic channel network |
| US20050095578A1 (en) * | 2003-10-31 | 2005-05-05 | Koller Manfred R. | Method and apparatus for cell permeabilization |
| US7425426B2 (en) * | 2004-03-15 | 2008-09-16 | Cyntellect, Inc. | Methods for purification of cells based on product secretion |
| CN104974983A (zh) | 2004-03-29 | 2015-10-14 | 英格朗公司 | 用于授精的精子悬浮液 |
| JP2005333889A (ja) * | 2004-05-27 | 2005-12-08 | Cybox Co Ltd | 細胞壊死方法及び細胞壊死装置 |
| MX2007000888A (es) * | 2004-07-22 | 2007-04-02 | Monsanto Technology Llc | Procedimiento para enriquecer una poblacion de celulas de esperma. |
| EP1787101B1 (en) | 2004-09-09 | 2014-11-12 | Life Technologies Corporation | Laser microdissection apparatus and method |
| WO2006088154A1 (ja) * | 2005-02-18 | 2006-08-24 | Absize Inc. | 細胞分離方法及び装置 |
| US20070178067A1 (en) * | 2005-11-09 | 2007-08-02 | John Maier | System and method for cytological analysis by raman spectroscopic imaging |
| EP2304020B1 (en) | 2008-06-30 | 2018-11-07 | Microbix Biosystems Inc. | Method and apparatus for sorting cells |
| EP2385993B1 (en) * | 2009-01-09 | 2016-03-30 | Intrexon Corporation | Genetic analysis of cells |
| US8788213B2 (en) | 2009-01-12 | 2014-07-22 | Intrexon Corporation | Laser mediated sectioning and transfer of cell colonies |
| US8665439B2 (en) * | 2009-06-30 | 2014-03-04 | Microbix Biosystems, Inc. | Method and apparatus for limiting effects of refraction in cytometry |
| US8638995B2 (en) | 2009-11-10 | 2014-01-28 | Illumigyn Ltd. | Optical speculum |
| US9271640B2 (en) | 2009-11-10 | 2016-03-01 | Illumigyn Ltd. | Optical speculum |
| US9877644B2 (en) | 2009-11-10 | 2018-01-30 | Illumigyn Ltd. | Optical speculum |
| DE102009060490A1 (de) * | 2009-12-22 | 2011-06-30 | Carl Zeiss Microlmaging GmbH, 07745 | Hochauflösendes Mikroskop und Bildteileranordnung |
| US9134301B2 (en) * | 2010-11-22 | 2015-09-15 | Bio-Rad Laboratories, Inc. | Sorting of adherent cells by selective transformation of labels |
| CA2826914C (en) | 2011-02-15 | 2020-12-01 | Microbix Biosystems Inc. | Methods, systems, and apparatus for performing flow cytometry |
| JP5333538B2 (ja) | 2011-07-27 | 2013-11-06 | 株式会社デンソー | 弾性表面波センサ |
| US9279802B2 (en) | 2011-09-27 | 2016-03-08 | Shimadzu Corporation | Cell sorter and cell sorting method |
| TWI588199B (zh) | 2012-05-25 | 2017-06-21 | 羅門哈斯公司 | 光擴散聚合物組成物、製造該光擴散聚合物組成物的方法以及由之製得的物品 |
| US8808644B2 (en) * | 2012-08-20 | 2014-08-19 | Biochemical Diagnostics, Inc. | Methods for dispensing fluids into microplates utilizing microwell covers |
| CA2924274C (en) * | 2013-09-18 | 2022-03-15 | Illumigyn Ltd. | Optical speculum |
| WO2015142923A1 (en) * | 2014-03-17 | 2015-09-24 | Carnegie Mellon University | Methods and systems for disease classification |
| US9999785B2 (en) | 2014-05-30 | 2018-06-19 | Dr. Todd Frank Ovokaitys | Method and system for generation and use of activated stem cells |
| US10202598B2 (en) | 2014-05-30 | 2019-02-12 | Todd Frank Ovokaitys | Methods and systems for generation, use, and delivery of activated stem cells |
| US10384985B2 (en) | 2014-06-06 | 2019-08-20 | B.K. Consultants, Inc. | Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants |
| WO2015187974A1 (en) | 2014-06-06 | 2015-12-10 | Ovokaitys Todd Frank | Methods and compositions for increasing the bioactivity of nutrients |
| US11291931B2 (en) | 2014-12-15 | 2022-04-05 | Akadeum Life Sciences, Inc. | Method and system for buoyant separation |
| US10324080B2 (en) * | 2015-11-17 | 2019-06-18 | Purdue Research Foundation | Systems and methods for automated image-guided patch-clamp electrophysiology in vitro |
| JP6033980B1 (ja) * | 2016-06-01 | 2016-11-30 | 株式会社片岡製作所 | 細胞処理システム |
| JP6541160B2 (ja) | 2017-02-13 | 2019-07-10 | 株式会社片岡製作所 | 細胞処理装置および対象物の処理方法 |
| JP6532063B2 (ja) * | 2017-02-13 | 2019-06-19 | 株式会社片岡製作所 | 細胞処理装置 |
| US11427804B2 (en) * | 2018-06-15 | 2022-08-30 | Abs Global, Inc. | Apparatus and method for cell kill confirmation |
| JP6574028B1 (ja) * | 2018-06-29 | 2019-09-11 | 株式会社片岡製作所 | 細胞処理装置および細胞のレーザ処理方法 |
| JP7189314B2 (ja) | 2018-07-09 | 2022-12-13 | アカデューム ライフ サイエンセズ，インコーポレイテッド | 浮遊性粒子を処理するシステムおよび方法 |
| JP2021129555A (ja) * | 2020-02-18 | 2021-09-09 | 株式会社島津製作所 | 細胞精製装置および細胞精製方法 |
| JP2023552806A (ja) | 2020-12-08 | 2023-12-19 | フランク オヴォカイツ トッド | 幹細胞の増産のための方法およびシステム |
| WO2022269389A1 (en) * | 2021-06-21 | 2022-12-29 | Evolution Optiks Limited | Electromagnetic energy directing system, and method using same |
| US11819842B2 (en) | 2021-08-26 | 2023-11-21 | Akadeum Life Sciences, Inc. | Method and system for buoyant separation |
| WO2023191984A1 (en) | 2022-04-01 | 2023-10-05 | Akadeum Life Sciences, Inc. | Method and system for buoyant-particle-assisted cell therapy |
| EP4646244A1 (en) | 2023-02-14 | 2025-11-12 | Akadeum Life Sciences, Inc. | Method and system for partially or fully automated buoyancy-assisted separation |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3674926A (en) | 1968-10-15 | 1972-07-04 | Reynolds Metals Co | Feature counter with improved masking and grey level detection |
| JPS53135660A (en) * | 1977-04-30 | 1978-11-27 | Olympus Optical Co Ltd | Fluorescent photometric microscope using laser light |
| US4803992A (en) * | 1980-10-28 | 1989-02-14 | Lemelson Jerome H | Electro-optical instruments and methods for producing same |
| US4395397A (en) * | 1981-09-17 | 1983-07-26 | Sidney Farber Cancer Institute, Inc. | Apparatus and method for killing unwanted cells |
| IL68507A (en) * | 1982-05-10 | 1986-01-31 | Univ Bar Ilan | System and methods for cell selection |
| US5272081A (en) * | 1982-05-10 | 1993-12-21 | Bar-Ilan University | System and methods for cell selection |
| US4629687A (en) * | 1982-07-29 | 1986-12-16 | Board Of Trustees Of Michigan State University | Positive selection sorting of cells |
| US4624915A (en) * | 1982-07-29 | 1986-11-25 | Board Of Trustees Of Michigan State University | Positive selection sorting of cells |
| US4532402A (en) * | 1983-09-02 | 1985-07-30 | Xrl, Inc. | Method and apparatus for positioning a focused beam on an integrated circuit |
| JPS6083584A (ja) | 1983-10-13 | 1985-05-11 | Rikagaku Kenkyusho | 生細胞内への物質移入法 |
| US5103660A (en) | 1984-04-23 | 1992-04-14 | Johnson Virgil T | Removable steering wheel device, and methods of constructing and utilizing same |
| JP2522773B2 (ja) * | 1986-09-08 | 1996-08-07 | 新技術事業団 | 細胞識別・定量方法 |
| DE3689695T2 (de) * | 1986-11-13 | 1994-06-09 | Foodco Corp | Vorrichtung und verfahren zur aseptischen verpackung von nahrungsmitteln. |
| US5188633A (en) * | 1987-03-16 | 1993-02-23 | Michael Kratzer | Device for selective destruction of cells |
| DE3708511A1 (de) * | 1987-03-16 | 1988-09-29 | Kratzer Michael | Einrichtung zur selektiven zerstoerung von zellen |
| JPH07122902B2 (ja) | 1987-04-17 | 1995-12-25 | 株式会社日立製作所 | 細胞位置検出装置 |
| HU204856B (en) * | 1987-08-12 | 1992-02-28 | Orszagos Mueszaki Fejlesztesi | Process for releasing cell mixtures and tissues from undesired populations and for producing monoclonal antibody - hematoporphyrin conjugates |
| JPH074222B2 (ja) * | 1988-05-20 | 1995-01-25 | 農業生物資源研究所長 | 細胞破砕選別装置及び選択的遺伝子導入装置 |
| US5089384A (en) * | 1988-11-04 | 1992-02-18 | Amoco Corporation | Method and apparatus for selective cell destruction using amplified immunofluorescence |
| JPH02168160A (ja) * | 1988-12-22 | 1990-06-28 | Omron Tateisi Electron Co | 細胞選別装置 |
| JP2700702B2 (ja) * | 1989-11-20 | 1998-01-21 | 浜松ホトニクス株式会社 | 医療装置用レーザ発生装置 |
| DE59004780D1 (de) | 1989-12-22 | 1994-04-07 | Asea Brown Boveri | Faseroptischer Sensor. |
| US5622853A (en) * | 1990-05-01 | 1997-04-22 | Becton Dickinson And Company | T lymphocyte precursor |
| US5202230A (en) | 1990-09-07 | 1993-04-13 | Kamentsky Louis A | Methods of detecting cut cells in a tissue section |
| EP0501688A1 (en) | 1991-02-27 | 1992-09-02 | Hitachi, Ltd. | Apparatus and method for applying a laser beam through a microscope |
| US5298963A (en) * | 1992-02-26 | 1994-03-29 | Mitsui Mining & Smelting Co., Ltd. | Apparatus for inspecting the surface of materials |
| US6007814A (en) | 1992-06-15 | 1999-12-28 | Sloan-Kettering Institute For Cancer Research | Therapeutic uses of the hypervariable region of monoclonal antibody M195 and constructs thereof |
| RU2054486C1 (ru) | 1992-09-01 | 1996-02-20 | Валерий Георгиевич Петухов | Способ идентификации микроорганизмов |
| US6315772B1 (en) | 1993-09-24 | 2001-11-13 | Transmedica International, Inc. | Laser assisted pharmaceutical delivery and fluid removal |
| CA2102884A1 (en) | 1993-03-04 | 1994-09-05 | James J. Wynne | Dental procedures and apparatus using ultraviolet radiation |
| US5422720A (en) | 1993-07-21 | 1995-06-06 | Becton Dickinson And Company | Blood culture sensor station utilizing two distinct light sources |
| US5381224A (en) * | 1993-08-30 | 1995-01-10 | A. E. Dixon | Scanning laser imaging system |
| EP0662512A3 (en) * | 1993-12-20 | 1997-01-15 | Becton Dickinson Co | Human hematopoietic stem cells. |
| US5932872A (en) * | 1994-07-01 | 1999-08-03 | Jeffrey H. Price | Autofocus system for scanning microscopy having a volume image formation |
| US5795755A (en) | 1994-07-05 | 1998-08-18 | Lemelson; Jerome H. | Method of implanting living cells by laser poration at selected sites |
| US5523543A (en) | 1994-09-09 | 1996-06-04 | Litel Instruments | Laser ablation control system and method |
| AU3963595A (en) * | 1994-12-08 | 1996-06-26 | Molecular Dynamics, Inc. | Fluorescence imaging system employing a macro scanning objective |
| JP3077539B2 (ja) * | 1994-12-22 | 2000-08-14 | 松下電器産業株式会社 | レーザ加工方法 |
| US6148096A (en) | 1995-09-15 | 2000-11-14 | Accumed International, Inc. | Specimen preview and inspection system |
| US6040139A (en) | 1995-09-19 | 2000-03-21 | Bova; G. Steven | Laser cell purification system |
| US5646411A (en) * | 1996-02-01 | 1997-07-08 | Molecular Dynamics, Inc. | Fluorescence imaging system compatible with macro and micro scanning objectives |
| WO1997039851A2 (en) | 1996-04-25 | 1997-10-30 | The Gleason Works | Cutting tool for toothed articles |
| US6122396A (en) | 1996-12-16 | 2000-09-19 | Bio-Tech Imaging, Inc. | Method of and apparatus for automating detection of microorganisms |
| US5874266A (en) * | 1997-03-27 | 1999-02-23 | Palsson; Bernhard O. | Targeted system for removing tumor cells from cell populations |
| US6514722B2 (en) * | 1997-03-27 | 2003-02-04 | Oncosis | Method and apparatus for selectively targeting specific cells within a cell population |
| US6753161B2 (en) | 1997-03-27 | 2004-06-22 | Oncosis Llc | Optoinjection methods |
| WO1998052016A1 (en) | 1997-05-09 | 1998-11-19 | Morphometrix Technologies Inc. | Multi-spectral imaging system and method for cytology |
| US6005256A (en) | 1998-02-12 | 1999-12-21 | Raytheon Company | Method and apparatus for performing cell analysis based on simultaneous multiple marker emissions from neoplasia (CASMMEN) |
| US6642018B1 (en) * | 1998-03-27 | 2003-11-04 | Oncosis Llc | Method for inducing a response in one or more targeted cells |
| US6424863B1 (en) | 1999-03-26 | 2002-07-23 | Stephen T. Flock | Delivery of pharmaceutical compounds and collection of biomolecules using electromagnetic energy and uses thereof |
| US6381224B1 (en) | 1999-03-31 | 2002-04-30 | Motorola, Inc. | Method and apparatus for controlling a full-duplex communication system |
-
1997
- 1997-03-27 US US08/824,968 patent/US5874266A/en not_active Expired - Lifetime
-
1998
- 1998-03-27 WO PCT/US1998/006125 patent/WO1998042356A1/en not_active Ceased
- 1998-03-27 JP JP54328698A patent/JP4512206B2/ja not_active Expired - Fee Related
- 1998-03-27 CA CA002281112A patent/CA2281112A1/en not_active Abandoned
- 1998-03-27 BR BR9808068-7A patent/BR9808068A/pt not_active Application Discontinuation
- 1998-03-27 AT AT98913223T patent/ATE349220T1/de not_active IP Right Cessation
- 1998-03-27 CN CN98803760A patent/CN1251528A/zh active Pending
- 1998-03-27 DE DE69836747T patent/DE69836747T2/de not_active Expired - Lifetime
- 1998-03-27 KR KR1019997007829A patent/KR20000075758A/ko not_active Ceased
- 1998-03-27 EP EP98913223A patent/EP1011697B1/en not_active Expired - Lifetime
- 1998-03-27 AU AU67826/98A patent/AU743239B2/en not_active Ceased
- 1998-03-27 US US09/049,677 patent/US6143535A/en not_active Expired - Lifetime
-
2003
- 2003-01-09 US US10/341,333 patent/US7129070B2/en not_active Expired - Fee Related
-
2009
- 2009-08-21 JP JP2009209779A patent/JP2010029193A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190025251A (ko) * | 2017-09-01 | 2019-03-11 | 주식회사 코어파마 | 순환암세포를 선택적으로 사멸시키는 시스템 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1011697B1 (en) | 2006-12-27 |
| ATE349220T1 (de) | 2007-01-15 |
| EP1011697A1 (en) | 2000-06-28 |
| AU743239B2 (en) | 2002-01-24 |
| EP1011697A4 (en) | 2002-11-20 |
| DE69836747D1 (de) | 2007-02-08 |
| DE69836747T2 (de) | 2007-10-04 |
| CN1251528A (zh) | 2000-04-26 |
| JP4512206B2 (ja) | 2010-07-28 |
| US7129070B2 (en) | 2006-10-31 |
| AU6782698A (en) | 1998-10-20 |
| US5874266A (en) | 1999-02-23 |
| BR9808068A (pt) | 2000-03-08 |
| CA2281112A1 (en) | 1998-10-01 |
| JP2010029193A (ja) | 2010-02-12 |
| WO1998042356A1 (en) | 1998-10-01 |
| US20030138923A1 (en) | 2003-07-24 |
| JP2002511843A (ja) | 2002-04-16 |
| US6143535A (en) | 2000-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20000075758A (ko) | 세포 집단으로부터 종양 세포를 제거하기위한 시스템 | |
| EP2281879B1 (en) | Apparatus for determining a morphological or physiological characteristic of individual cells in a biological specimen | |
| US7092557B2 (en) | Method and device for selectively targeting cells within a three-dimensional specimen | |
| US6642018B1 (en) | Method for inducing a response in one or more targeted cells | |
| AU2002232892A1 (en) | Method and device for selectively targeting cells within a three -dimensional specimen | |
| MXPA99008715A (es) | Sistema dirigido para remover celulas tumorales de poblaciones celulares |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0105 | International application |
Patent event date: 19990826 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20011130 Patent event code: PE09021S01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20030627 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20030929 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20030627 Comment text: Notification of reason for refusal Patent event code: PE06011S01I Patent event date: 20011130 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |